Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer’s disease, and stop their production. The researchers used computer-based methods to develop antibodies—the star players of the body’s natural defence system—to target the deposits of misfolded proteins which are a hallmark of Alzheimer’s disease. Early...